Department of Ophthalmology & Visual Sciences, University of Iowa, Iowa City, IA, USA.
Cornea. 2010 Jun;29(6):601-6. doi: 10.1097/ICO.0b013e3181c11de4.
To report the visual acuity, refractive outcome, and endothelial cell density (ECD) up to 1 year after deep lamellar endothelial keratoplasty (DLEK) in a large prospective series.
Eighty-six DLEK procedures were performed and evaluated in a prospective interventional case series. Subgroup analysis was performed to compare results from large-incision (9 mm) DLEK (n = 7), small-incision (5-8 mm) DLEK (n = 70), and penetrating keratoplasty (PKP) conversion (n = 9). Outcome measures included best-corrected visual acuity (BCVA), manifest refraction, corneal topographic astigmatism, and ECD.
The percentage of eyes that achieved a BCVA of 20/40 or better after DLEK was 55% at 6 months, increasing to 61% at 1 year. Topographic astigmatism and spherical equivalent were not significantly different than preoperative measurements up to 1 year after DLEK (P > 0.05). An endothelial cell loss of 40% at 6 months and 48% by 1 year was observed. The mean ECD after DLEK was 1831 +/- 472 cells per square millimeter at 6 months and 1569 +/- 601 cells per square millimeter at 12 months. When evaluated by incision size, the ECD was better at 2066 +/- 558 cells per square millimeter with a 9-mm incision compared with only 1516 +/- 585 cells per square millimeter with a smaller incision at 1 year, although this did not reach significance (P = 0.075). The endothelial cell loss after penetrating keratoplasty conversion was similar to that in the large-incision group (P > 0.05).
DLEK provides good visual acuity (> or =20/40) for the majority of patients at 1 year with stable refractive error compared with baseline. Refractive stability was observed with both large- and small-incision DLEKs; however, worrisome endothelial cell loss was observed, especially with a small-incision technique.
报告在一个大型前瞻性系列研究中,深层板层角膜内皮移植术(DLEK)后 1 年的视力、屈光结果和内皮细胞密度(ECD)。
对 86 例 DLEK 手术进行前瞻性干预性病例系列研究,并进行评估。亚组分析比较了大切口(9mm)DLEK(n=7)、小切口(5-8mm)DLEK(n=70)和穿透性角膜移植术(PKP)转换(n=9)的结果。观察指标包括最佳矫正视力(BCVA)、显性折射、角膜地形散光和 ECD。
DLEK 术后 6 个月,55%的眼视力达到 20/40 或更好,1 年后增加到 61%。DLEK 术后 1 年内,角膜散光和等效球镜度数与术前测量值无显著差异(P>0.05)。术后 6 个月和 1 年时,观察到内皮细胞丢失 40%和 48%。DLEK 术后 6 个月时平均 ECD 为 1831±472 个细胞/平方毫米,12 个月时为 1569±601 个细胞/平方毫米。按切口大小评估时,9mm 切口的 ECD 较好,为 2066±558 个细胞/平方毫米,而小切口的 ECD 仅为 1516±585 个细胞/平方毫米,但差异无统计学意义(P=0.075)。穿透性角膜移植术转换后的内皮细胞丢失与大切口组相似(P>0.05)。
DLEK 术后 1 年,大多数患者视力良好(≥20/40),与基线相比,屈光状态稳定。大切口和小切口 DLEK 均观察到屈光稳定,但内皮细胞丢失令人担忧,尤其是小切口技术。